Intravenous prenalterol in acute and chronic heart failure.
D000318:Adrenergic beta-Agonists / Q000008:administration & dosage*; D000368:Aged; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D002302:Cardiac Output / Q000187:drug effects; D002303:Cardiac Output, Low / Q000188:drug therapy; D003327:Coronary Disease / Q000188:drug therapy* / Q000503:physiopathology; D004280:Dobutamine / Q000008:administration & dosage; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D004562:Electrocardiography; D005260:Female; D006207:Half-Life; D006352:Heart Ventricles / Q000503:physiopathology; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D007263:Infusions, Parenteral; D008297:Male; D008875:Middle Aged; D009200:Myocardial Contraction / Q000187:drug effects; D011217:Practolol / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D011294:Prenalterol; D013318:Stroke Volume / Q000187:drug effects; D013610:Tachycardia / Q000139:chemically induced; D014655:Vascular Resistance / Q000187:drug effects
D000318:Adrenergic beta-Agonists; D004280:Dobutamine; D011294:Prenalterol; D011217:Practolol